All Access Articles |
- Arvinas Provides Update on Phase 3 Trials | 2025-01-10 | PHARMACEUTICAL
- Arvinas and Pfizer Release Promising Data for Breast Cancer Treatment | 2024-12-10 | PHARMACEUTICAL
- Arvinas Reports Q2 Financials, Shares Drop 6.3% | 2024-07-30 | PHARMACEUTICAL